For instance, the 2012 the Kidney Disease: Improving Global Outcomes (KDIGO) guideline recommended that the Hb of patients with CKD should be controlled at 110–120 grams per liter (g/L), corresponding to an HCT of 33%–36%. The gene discussed is GSTM1; the disease is chronic kidney disease.